Skip to main content
SpringerLink
Log in

Antidementiva

  • Chapter
  • First Online:
Kompendium der Psychiatrischen Pharmakotherapie

Zusammenfassung

Indikationen, Wirkungsweise, Nebenwirkungen und Risiken, Kontraindikationen und Interaktionen werden für die Antidementiva im allgemeinen Teil und dann für jedes Arzneimittel spezifisch im Präparateteil beschrieben.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Bartels C, Wagner M, Wolfsgruber S et al (2018) Impact of SSRI Therapy on risk of conversion from mild cognitive impairment to Alzheimer’s dementia in individuals with previous depression. Am J Psychiatry 175(3):232–241

    Article  Google Scholar 

  • Buoli M, Serati M, Caldiroli A et al (2017) Pharmacological management of psychiatric symptoms in frontotemporal dementia: a systematic review. J Geriatr Psychiatry Neurol 30(3):162–169

    Article  Google Scholar 

  • Caraci F, Sultana J, Drago F, Spina E (2017) Clinically relevant drug interactions with anti-Alzheimer’s grugs. CNS Neurol Disord Drug Targets 16(4):501–513

    Article  CAS  Google Scholar 

  • Coupland CAC, Hill T, Dening T et al (2019) Anticholinergic drug exposure and the risk of dementia: a nested case-control study. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2019.0677

    Article  PubMed  PubMed Central  Google Scholar 

  • Forlenza OV, Radanovic M, Talib LL et al (2019) Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial. Br J Psychiatry 5:1–7

    Google Scholar 

  • Hefner G, Brueckner A, Hiemke C, Fellgiebel A (2015) Therapeutic drug monitoring for patients with Alzheimer dementia to improve treatment with donepezil. Ther Drug Monit 37(3):353–361

    Article  CAS  Google Scholar 

  • Howard R, McShane R, Lindesay J et al (2012) Donepezil and memantine for moderate-to-severe Alzheimer’s disease. N Engl J Med 366(10):893–903

    Article  CAS  Google Scholar 

  • Huang LK, Chao SP, Hu CJ (2020) Clinical trials of new drugs for Alzheimer disease. J Biomed Sci 27(1):18

    Article  CAS  Google Scholar 

  • Jack CR Jr, Bennett DA, Blennow K et al (2018) Toward a biological definition of Alzheimer’s disease. Alzheimers Dement 14(4):535–562

    Article  Google Scholar 

  • Lange-Asschenfeldt C (2013) Vaskuläre Faktoren in der Pathogenese der Alzheimer-Krankheit. Nervenarzt 84(6):732–737

    Article  CAS  Google Scholar 

  • McKeith IG, Boeve BF, Dickson DW et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89(1):88–100

    Article  Google Scholar 

  • Novak P, Schmidt R, Kontsekova E et al (2017) Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Neurol 16(2):123–134

    Article  CAS  Google Scholar 

  • Orgeta V, Tabet N, Nilforooshan R, Howard R (2017) Efficacy of antidepressants for depression in Alzheimer’s disease: systematic review and meta-analysis. J Alzheimers Dis 58(3):725–733

    Article  CAS  Google Scholar 

  • Padala PR, Padala KP, Lensing SY et al (2018) Methylphenidate for apathy in community dwelling older veterans with mild Alzheimer’s disease: a double-blind, randomized, placebo-controlled trial. Am J Psychiatry 175(2):159–168

    Article  Google Scholar 

  • Pase MP, Beiser AS, Himali JJ et al (2019) Assessment of plasma total tau level as a predictive biomarker for dementia and related endophenotypes. JAMA Neurol 76(5):598–606

    Article  Google Scholar 

  • Saarelainen L, Tolppanen AM, Koponen M et al (2017) Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: a matched cohort study. Int J Geriatr Psychiatry 33(4):583–590

    Article  Google Scholar 

  • Schindler SE, Bollinger JG, Ovod V et al (2019) High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis. Neurology 93(17):e1647–e1659

    CAS  PubMed  PubMed Central  Google Scholar 

  • Smith R, Wibom M, Pawlik D et al (2019) Correlation of in vivo [18F]flortaucipir with postmortem Alzheimer disease tau pathology. JAMA Neurol 76(3):310–317

    Article  Google Scholar 

  • Sondergaard KB, Weeke P, Wissenberg M et al (2017) Non-steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: a nationwide case-time-control study. Eur Heart J Cardiovasc Pharmacother 3(2):100–107

    PubMed  Google Scholar 

  • Tan MS, Yu JT, Tan CC et al (2015) Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. J Alzheimers Dis 43(2):589–603

    Article  CAS  Google Scholar 

  • Thant T, Yager J (2019) Updating apathy: using research domain criteria to inform clinical assessment and diagnosis of disorders of motivation. J Nerv Ment Dis 207(9):707–714

    Article  Google Scholar 

  • Tsoi KK, Chan JY, Chan FC et al (2019) Monotherapy is good enough for patients with mild-to-moderate Alzheimer’s disease: a network meta-analysis of 76 randomized controlled trials. Clin Pharmacol Ther 105(1):121–130

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Düsseldorf/Kaarst, Deutschland

    Prof. Dr. med. Christian Lange-Asschenfeldt

  2. Mainz, Deutschland

    Otto Benkert

Authors
  1. Prof. Dr. med. Christian Lange-Asschenfeldt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Otto Benkert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Otto Benkert .

Editor information

Editors and Affiliations

  1. ehemals Universitäts-Klinikum Mainz, Mainz, Germany

    Otto Benkert

  2. Klinik für Psychiatrie und Psychotherapie, ehemals Universitäts-Klinikum München Campus Innenstadt, München, Germany

    Hanns Hippius

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lange-Asschenfeldt, C., Benkert, O. (2021). Antidementiva. In: Benkert, O., Hippius, H. (eds) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-61753-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-61753-3_6

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-61752-6

  • Online ISBN: 978-3-662-61753-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation